LISA HOPF: Open Payments
NPI 1154684991 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 56 payments from 17 companies in 2025. Trend: 2023 $1,046 · 2024 $542 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 13 | $266 |
| GlaxoSmithKline, LLC. | 10 | $199 |
| Merck Sharp & Dohme LLC | 5 | $81 |
| Novartis Pharmaceuticals Corporation | 5 | $75 |
| Eisai Inc. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Astellas Pharma US Inc | 3 | $60 |
| Caris MPI, Inc. | 1 | $36 |
| Agios Pharmaceuticals, Inc. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $33 |
Products named: Enhertu, JEMPERLI, INJECTAFER, Lenvima, OJJAARA, LYNPARZA, KISQALI, KEYTRUDA.
Industry payments across NJ — which companies pay providers there.
